Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones en la fuente HAEMOPHILIA

Tipo Año Título Fuente
Artículo2024Humanistic burden of haemophilia A without inhibitors: A cross-sectional analysis of the HemoLIFE studyHAEMOPHILIA
Resumen congreso2023ACQUIRED HAEMOPHILIAHAEMOPHILIA
Resumen congreso2022ACQUIRED VON WILLEBRAND DISEASE AND CHRONIC LYMPHOCYTIC LEUKAEMIA: REMISSION AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATIONHAEMOPHILIA
Resumen congreso2021RESULTS FROM A 52-WEEK, PROSPECTIVE, NONINTERVENTIONAL STUDY OF INDIVIDUALS WITH SEVERE HAEMOPHILIA A RECEIVING PROPHYLAXIS: RATES OF BLEEDING, FVIII USE, AND QUALITY OF LIFEHAEMOPHILIA
Resumen congreso2021RESULTS FROM A PHASE 1/2 SAFETY AND DOSE ESCALATION STUDY OF TAK-754, AN AAV8 VECTOR WITH A CODON-OPTIMIZED B-DOMAIN-DELETED FACTOR VIII TRANSGENE IN SEVERE HEMOPHILIA AHAEMOPHILIA
Artículo2021Type 2N VWD: Conclusions from the Spanish PCM-EVW-ES projectHAEMOPHILIA
Artículo2021Ultrasound evaluation of joint damage and disease activity in adult patients with severe haemophilia A using the HEAD-US systemHAEMOPHILIA
Artículo2020Adherence to prophylaxis in adult patients with severe haemophilia AHAEMOPHILIA
Resumen congreso2020BAY 81-8973 PROPHYLAXIS IN PATIENTS WITH HAEMOPHILIA A: INTERIM FINDINGS FOR CHILDREN <12 YEARS FROM THE TAURUS REAL-WORLD STUDYHAEMOPHILIA
Resumen congreso2020Development of an observatory of unmet needs and future trends on the management of people with hemophilia in SpainHAEMOPHILIA
Resumen congreso2020PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTSHAEMOPHILIA
Resumen congreso2020PK-guided switch from standard half-life to extended half-life factor VIII productsHAEMOPHILIA
Resumen congreso2019Adherence to prophylaxis in adult patients with severe haemophilia AHAEMOPHILIA
Resumen congreso2019Determinants of prophylaxis regimen choice for patients with haemophilia A switching to BAY 81-8973: Real-world findings from the TAURUS non-interventional studyHAEMOPHILIA
Resumen congreso2019TAURUS real-world study: Straightforward transition to BAY 81-8973 prophylaxis in patients with haemophilia A with maintained or reduced dosing frequencyHAEMOPHILIA
Artículo2018Improvement in clinical outcomes and replacement factor VIII use in patients with haemophilia A after factor VIII pharmacokinetic-guided prophylaxis based on Bayesian models with myPKFiT®HAEMOPHILIA
Letter2018Moderate and severe haemophilia in Spain: An epidemiological updateHAEMOPHILIA
Resumen congreso2018Safety and efficacy of fascial therapy in the treatment of hemophilic arthropathy of elbow: a pilot studyHAEMOPHILIA
Artículo2017Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: a case seriesHAEMOPHILIA
Artículo2016Evaluation of the utility of the ISTH-BAT in haemophilia carriers: a multinational studyHAEMOPHILIA
Letter2016FVIII inhibitor development according to concentrate: data from the EUHASS registry excluding overlap with other studiesHAEMOPHILIA
Artículo2015Adherence to prophylaxis and quality of life in children and adolescents with severe haemophilia AHAEMOPHILIA
Artículo2015Cost analysis of prophylaxis with activated prothrombin complex concentrate vs. on-demand therapy with activated factor VII in severe haemophilia A patients with inhibitors, in SpainHAEMOPHILIA
Artículo2015Presentation and management of acute coronary syndromes among adult persons with haemophilia: results of an international, retrospective, 10-year surveyHAEMOPHILIA
Resumen congreso2014Validation of the International Society on Thrombosis and Haemostasis Bleeding Assessment Tool (ISTH-BAT) in Hemophilia CarriersHAEMOPHILIA
Artículo2013High prevalence of radiolucent periapical lesions amongst patients with inherited coagulation disordersHAEMOPHILIA
Artículo2012Is on-demand treatment effective in patients with severe haemophilia?HAEMOPHILIA
Letter2012The international factor IX treatment network surveyHAEMOPHILIA
Artículo2011Prophylaxis therapy in haemophilia A: current situation in SpainHAEMOPHILIA
Resumen congreso2010Iliopsoas hematoma in patients with hemophilia and inhibitorHAEMOPHILIA
Resumen congreso2010Integral assessment of hemophilia carriers: new guideline from Spanish Foundation Victoria EugeniaHAEMOPHILIA
Resumen congreso2010Integral physiotherapeutic guidelines for hemophilia patients from Spanish Foundation Victoria EugeniaHAEMOPHILIA
Resumen congreso2010Optimum response to treatment of immunotolerance with octocog alfaHAEMOPHILIA
Resumen congreso2010Pharmacologic venous thromboembolism prophylaxis in haemophilic patients under major orthopaedic surgery: experience and safety profileHAEMOPHILIA
Resumen congreso2010The Spanish Immune Tolerance Induction Registry: 2009 updateHAEMOPHILIA
Resumen congreso2008Pharmacokinetics of FVIII in clinical practice:: resource optimization and effect on health and quality of life in hemophilia AHAEMOPHILIA
Letter2007Characterization of sequence breakpoints in two haemophiliac patients with large FVIII gene deletionsHAEMOPHILIA